Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cancer Genetics Inc (CGIX)

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - PNM, STND, CBMG, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

PNM : 49.11 (+0.02%)
STND : 32.87 (unch)
CBMG : 18.64 (+1.08%)
CGIX : 2.35 (+4.91%)
Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm

, /PRNewswire/ -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown , is investigating potential claims concerning whether the following proposed mergers are fair...

TGC : 1.1741 (-8.27%)
AKER : 1.8300 (-2.66%)
CGIX : 2.35 (+4.91%)
DNKN : 106.29 (+0.03%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm - CBMG, MVC, PTI, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

CBMG : 18.64 (+1.08%)
MVC : 8.51 (+0.71%)
PTI : 1.0500 (+3.96%)
CGIX : 2.35 (+4.91%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Cancer Genetics, Inc.

, /PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cancer Genetics, Inc. ("CGIX" or the "Company") (NASDAQ: CGIX) in connection...

CGIX : 2.35 (+4.91%)
Cancer Genetics Reports Third Quarter 2020 Financial Results

Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today financial and operating results for the quarter ended...

CGIX : 2.35 (+4.91%)
Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

RESI : 16.44 (-0.18%)
CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)
CXO : 63.37 (-1.80%)
Large Study Shows That A Simple Blood Test Can Accurately Differentiate Between Benign and Malignant Lesions

LONDON, Nov. 9, 2020 /PRNewswire/ -- A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy)...

CGIX : 2.35 (+4.91%)
Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter's Option to Purchase Additional Shares

Cancer Genetics, Inc. (Nasdaq: CGIX) ("Cancer Genetics" or "the Company"), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced the closing of its previously...

CGIX : 2.35 (+4.91%)
Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

Cancer Genetics, Inc. (Nasdaq: CGIX) ("Cancer Genetics"), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today that, due to demand, the underwriter has agreed...

CGIX : 2.35 (+4.91%)
Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering

Cancer Genetics, Inc. (Nasdaq: CGIX) ("Cancer Genetics"), a leader in in drug discovery and preclinical oncology and immuno-oncology services, announced today that it has entered into an underwriting agreement...

CGIX : 2.35 (+4.91%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

CGIX : 2.35 (+4.91%)
EIDX : 88.71 (+3.13%)
ARA : 11.44 (-0.09%)
MVC : 8.51 (+0.71%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)
EIDX : 88.71 (+3.13%)
VRTU : 49.95 (unch)
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - DCOM, ARA, CGIX, BLDR

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

DCOM : 15.80 (+3.13%)
ARA : 11.44 (-0.09%)
CGIX : 2.35 (+4.91%)
BLDR : 37.33 (+0.65%)
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited

, /PRNewswire/ --

ARA : 11.44 (-0.09%)
BMCH : 48.91 (+0.91%)
BLDR : 37.33 (+0.65%)
CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)
MR : 5.36 (-1.29%)
MYOK : 224.91 (+0.05%)
YIN : 7.25 (+0.14%)
Lifshitz Law Firm, P.C. Announces Investigation of BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and Varian Medical Systems, Inc. (NYSE: VAR)

BMC Stock Holdings, Inc. (NASDAQ:BMCH) - Builders FirstSource, Inc. (NASDAQ:BLDR)

MDSY : 0.73 (+4.29%)
BLDR : 37.33 (+0.65%)
CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)
VAR : 174.11 (-0.01%)
BMCH : 48.91 (+0.91%)
Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Genetics

MUMBAI, India and LONDON, Sept. 29, 2020 /PRNewswire/ -- A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that...

CGIX : 2.35 (+4.91%)
Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Genetics

and , /PRNewswire/ -- A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy...

CGIX : 2.35 (+4.91%)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH

, /PRNewswire/ --

CGIX : 2.35 (+4.91%)
YIN : 7.25 (+0.14%)
OTEL : 11.52 (unch)
BMCH : 48.91 (+0.91%)
Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)

, /PRNewswire/ --

AKCA : 18.17 (+0.17%)
BMCH : 48.91 (+0.91%)
BLDR : 37.33 (+0.65%)
CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)
OTEL : 11.52 (unch)
RST : 29.99 (unch)
VAR : 174.11 (-0.01%)
YIN : 7.25 (+0.14%)
Moore Kuehn Encourages BDGE, CBMG, CGIX, and BMCH Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

BMCH : 48.91 (+0.91%)
BDGE : 24.29 (+2.79%)
CGIX : 2.35 (+4.91%)
CBMG : 18.64 (+1.08%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar